Literature DB >> 12447672

Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.

Koji Yoshizawa1, Hideo Nagai, Shinji Sakurai, Mitsugu Hironaka, Shojiroh Morinaga, Ken Saitoh, Masashi Fukayama.   

Abstract

Histological criteria for subclassification of intraductal papillary mucinous tumor (IPMT) and mucinous cystic tumor (MCT) of the pancreas remain ambiguous in the absence of apparent invasion or metastasis. To elucidate this issue, we evaluated clonality and K- ras mutations in 11 cystic tumors of the pancreas from female patients, including 7 IPMTs and 4 MCTs. The analyses were performed on DNA from laser microdissected epithelia showing different degrees of atypia as well as normal-appearing epithelia (NAE) in the individual tumors. The grades of atypia were classified into three groups on conventional hematoxylin-eosin staining. Clonality was assessed using the methylation-induced polymorphic inactivation of the X-linked phosphoglycerate kinase gene. The incidence of monoclonality increased with the grades of atypia: 27% for NAE, 43% for grade 1, and 100% for grades 2 and 3. In three of four MCTs, foci of NAE were polyclonal, while monoclonality was seen in each one of grades 1 and 2. The frequency of K- ras mutation depended on the grades of atypia: 0% for NAE, 29% for grade 1, 50% for grade 2, and 75% for grade 3. Polyclonal epithelia were devoid of K- ras mutation in 92% of sites, while monoclonality was associated with both wild and mutational types in an approximately equal ratio. Both IPMT and MCT seem to arise from polyclonal epithelia and to be replaced by monoclonal neoplastic cells as they undergo dysplastic changes and K- ras mutation. These data suggest that the monoclonal expansion precedes K- ras mutation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12447672     DOI: 10.1007/s00428-002-0645-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  19 in total

Review 1.  Molecular analysis of cyst fluid aspiration in the diagnosis and risk assessment of cystic lesions of the pancreas.

Authors:  Sagar S Garud; Field F Willingham
Journal:  Clin Transl Sci       Date:  2011-12-08       Impact factor: 4.689

2.  Precursor lesions of pancreatic cancer.

Authors:  Suguru Yonezawa; Michiyo Higashi; Norishige Yamada; Masamichi Goto
Journal:  Gut Liver       Date:  2008-12-31       Impact factor: 4.519

Review 3.  Management of mucinous cystic neoplasms of the pancreas.

Authors:  Mario Testini; Angela Gurrado; Germana Lissidini; Pietro Venezia; Luigi Greco; Giuseppe Piccinni
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

4.  Intraductal papillary-mucinous neoplasia of the pancreas: Histopathology and molecular biology.

Authors:  Caroline S Verbeke
Journal:  World J Gastrointest Surg       Date:  2010-10-27

Review 5.  Precursors to pancreatic cancer.

Authors:  Ralph H Hruban; Anirban Maitra; Scott E Kern; Michael Goggins
Journal:  Gastroenterol Clin North Am       Date:  2007-12       Impact factor: 3.806

6.  Detection of K-ras point mutation and telomerase activity during endoscopic retrograde cholangiopancreatography in diagnosis of pancreatic cancer.

Authors:  Guo-Xiong Zhou; Jie-Fei Huang; Zhao-Shen Li; Guo-Ming Xu; Feng Liu; Hong Zhang
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

7.  Asymptomatic pancreatic lesions: new insights and clinical implications.

Authors:  Martin Loos; Christoph W Michalski; Jörg Kleeff
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

8.  Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma.

Authors:  Reena Shakya; Tamas Gonda; Michael Quante; Martha Salas; Samuel Kim; Jenna Brooks; Steffen Hirsch; Justine Davies; Angelica Cullo; Kenneth Olive; Timothy C Wang; Matthias Szabolcs; Benjamin Tycko; Thomas Ludwig
Journal:  Cancer Res       Date:  2012-11-29       Impact factor: 12.701

Review 9.  Malignant potential of intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Yoshiyuki Nakajima; Takatsugu Yamada; Masayuki Sho
Journal:  Surg Today       Date:  2010-08-26       Impact factor: 2.549

10.  Correlation between patterns of DNA mismatch repair hmlh1 and hmsh2 protein expression and progression of dysplasia in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Adriana Handra-Luca; Anne Couvelard; Claude Degott; Jean-François Fléjou
Journal:  Virchows Arch       Date:  2004-02-04       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.